Nutraceutical ingredient brand DolCas Biotech has announced the introduction of a new format for its Morikol marine collagen tripeptide ingredient.
The company said in a statement that the new delivery system will be on display at Vitafoods Europe 2026 in Barcelona, at booth #3G221.
The new format features 1 g and 2 g single-serving sachets of Morikol's collagen tripeptide, which is odour- and flavour-neutral.
The company added that the new 100% water-soluble sachets can be consumed directly without mixing or any aftertaste.
"This new format offers consumers a fast, convenient way to take collagen anywhere, anytime, which can also help support rapid absorption due to the highly bioavailable tripeptide structure," said K G Rao, founder and CEO of DolCas Biotech.
Conventional collagen peptides often recommend consumption on an empty stomach for optimal absorption, but when DolCas performed a comprehensive critical review of the ingredient, superior standardisation properties were revealed that made it unique compared to other collagen products.
DolCas emphasised that Morikol's key advantage lies in its high concentration of a specific GPH tripeptide sequence, which the body naturally recognises.
This is unlike conventional collagen peptides, which are broken down into amino acids.
Once absorbed, GPH tripeptides not only act as building blocks for collagen but also activate fibroblasts — cells that produce collagen, elastin and extracellular matrix proteins.
Additionally, emerging research suggests that GPH supports skin hydration and elasticity, helping soften rough skin and reduce wrinkles.
In placebo-controlled human studies, it demonstrated significant improvements across key skin health parameters.
It has also shown potential to support connective tissue health, including tendons, ligaments, joints and bone, contributing to collagen turnover and regeneration within musculoskeletal tissues.
This could open opportunities for applications in joint health, sports nutrition and healthy ageing formulations.
Morikol is produced from the up-scaled skin of ASC-certified freshwater tilapia via a specialised enzymatic hydrolysis process custom-designed to generate bioactive collagen tripeptides.
This proprietary manufacturing process ensures standardised levels of total tripeptides, Gly–X–Y (GXY) peptides and Gly–Pro–Hyp (GPH) peptides.
In its announcement, DolCas called its Morikol ingredient a "groundbreaking collagen ingredient" that offers proven clinical efficacy and exceptional formulation versatility, setting a new standard for nutricosmetics and beyond.
"Most collagen products function simply as amino acid sources," added Rao, "Morikol is fundamentally different."
By delivering bioactive GPH tripeptides that activate fibroblasts and stimulate collagen and hyaluronic acid synthesis at the cellular level, Morikol acts not just as collagen protein but as a targeted bioactive signalling system designed to support skin and connective tissue health from within.